Trial Profile
A Study to Evaluate the Long-term Efficacy and Safety of OK-432 Sclerotherapy in Patients with Lymphatic Malformations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Picibanil (Primary)
- Indications Lymphangioma
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2015 New trial record